Acme United (ACU) Earnings Date & Reports

Key Takeaways

• Analysts expect Q1 2026 EPS of around $0.48-$0.56, up from $0.41 in Q1 2025.
• Consensus revenue forecast stands at approximately $48-$52 million, reflecting 4-13% growth year-over-year.
• First aid and medical products remain a growth driver, following strong performance in prior quarters.
• Company's fiscal year ends December 31; Q1 covers January-March 2026, traditionally a softer period due to seasonality.
• Earnings release slated for mid-April 2026, with focus on guidance amid tariff and supply chain concerns.

Earnings Context and Why It Matters

Acme United Corporation (ACU), a supplier of cutting tools, measuring instruments, and safety products for school, home, office, and industrial markets, faces heightened investor scrutiny ahead of its Q1 2026 earnings. Following record full-year 2025 sales of $196.5 million and net income of $10.2 million, the company demonstrated resilience amid tariff uncertainties and shifting demand. Q1 results will shed light on sustained momentum in first aid sales, which surged 14% last year, and potential headwinds in school products. For investors, this report offers insights into margin trends, inventory levels, and forward guidance, critical in a volatile consumer goods sector influenced by economic conditions and trade policies.

Earnings Expectations

Wall Street anticipates consensus EPS of $0.48 for the first quarter ended March 31, 2026, with estimates ranging from $0.40 to $0.55, representing potential growth of about 17% from $0.41 reported in Q1 2025. Revenue expectations hover around $48.16 million per one analyst projection, implying 4.8% growth from $45.96 million last year, though some sources point to $51.86 million. Investors will watch gross margins, expected to benefit from first aid segment strength, and operating expenses amid ongoing supply chain dynamics.

Historically, Acme United has shown mixed beats: Q4 2025 EPS of $0.46 topped estimates, while revenue aligned closely at $47.5 million. The stock has reacted variably post-earnings, underscoring focus on guidance. Key metrics include U.S. segment performance and Europe growth, up 22% in Q4 local currency.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your analysis.

Market Reaction and Investor Sentiment

Heading into Q1 earnings, sentiment is cautiously optimistic, buoyed by 2025's record results but tempered by tariff risks and softer school/office demand. ACU shares trade around $44.81 as of April 10, 2026, down 2.35% recently amid broader market pressures. Key risks include currency fluctuations in Europe and potential inventory adjustments. Historically, post-earnings moves average modest, with beats driving 1-5% gains.

Forward Outlook and Key Factors to Monitor

Investors should track management's commentary on 2026 guidance, building on full-year 2025 net debt reduction to $18.5 million. First aid remains pivotal, with acquisitions like My Medic bolstering expansion.

Monitor tariff impacts on school products, where order cancellations hurt prior results, and European momentum. Gross margin expansion from automation and pricing will be crucial amid cost pressures.

Upcoming catalysts include Q2 back-to-school trends and free cash flow generation, which hit $12 million in Q1 2025. Broader industry dynamics, like consumer spending and supply chain stability, will shape demand signals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations